Burlington Stores (BURL) 10-Q 26 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Jul. 31, 2021shares
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jul. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Trading Symbol	BURL
Entity Registrant Name	BURLINGTON STORES, INC.
Entity Central Index Key	0001579298
Current Fiscal Year End Date	--01-29
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding	66,724,476
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-36107
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	80-0895227
Entity Address, Address Line One	2006 Route 130 North
Entity Address, City or Town	Burlington
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08016
City Area Code	609
Local Phone Number	387-7800
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
REVENUES:
Net sales	$ 2,212,812	$ 1,009,882	$ 4,403,479	$ 1,807,877
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Other revenue	$ 3,099	$ 2,446	$ 5,728	$ 5,974
Total revenue	2,215,911	1,012,328	4,409,207	1,813,851
COSTS AND EXPENSES:
Cost of sales	1,279,685	547,550	2,521,873	1,329,734
Selling, general and administrative expenses	702,291	491,598	1,367,119	976,686
Costs related to debt issuances and amendments	3,331		3,331	4,352
Depreciation and amortization	62,814	54,404	118,424	108,694
Impairment charges - long-lived assets	970	1,077	1,747	3,001
Other income - net	(5,841)	(824)	(7,214)	(2,946)
Loss on extinguishment of debt	31,395		31,395	202
Interest expense	17,502	28,359	37,101	43,052
Total costs and expenses	2,092,147	1,122,164	4,073,776	2,462,775
Income (loss) before income tax expense (benefit)	123,764	(109,836)	335,431	(648,924)
Income tax expense (benefit)	21,210	(63,055)	61,847	(268,415)
Net income (loss)	$ 102,554	$ (46,781)	$ 273,584	$ (380,509)
Net income (loss) per common stock - basic	$ 1.54	$ (0.71)	$ 4.11	$ (5.79)
Net income (loss) per common stock - diluted	$ 1.50	$ (0.71)	$ 4.01	$ (5.79)
Weighted average number of common stock - basic	66,636	65,947	66,516	65,760
Weighted average number of common stock - diluted	68,448	65,947	68,240	65,760

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 102,554	$ (46,781)	$ 273,584	$ (380,509)
Interest rate derivative contracts:
Net unrealized losses arising during the period	(5,083)	(1,982)	(4,258)	(11,591)
Net reclassification into earnings during the period	2,519	2,049	4,678	3,157
Other comprehensive income (loss), net of tax	(2,564)	67	420	(8,434)
Total comprehensive income (loss)	$ 99,990	$ (46,714)	$ 274,004	$ (388,943)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Current assets:
Cash and cash equivalents	$ 1,344,318	$ 1,380,276	$ 1,077,146
Restricted cash and cash equivalents	6,582	6,582	6,582
Accounts receivable—net	78,761	62,161	50,255
Merchandise inventories	828,152	740,788	607,554
Assets held for disposal	2,500	6,655
Prepaid and other current assets	403,602	314,154	150,253
Total current assets	2,663,915	2,510,616	1,891,790
Property and equipment—net	1,467,399	1,438,863	1,431,476
Operating lease assets	2,506,985	2,469,366	2,457,553
Tradenames	238,000	238,000	238,000
Goodwill	47,064	47,064	47,064
Deferred tax assets	4,197	4,422	4,678
Other assets	64,941	72,761	299,373
Total assets	6,992,501	6,781,092	6,369,934
Current liabilities:
Accounts payable	979,973	862,638	492,349
Current operating lease liabilities	326,282	304,629	277,211
Other current liabilities	483,134	512,830	451,877
Current maturities of long term debt	14,095	3,899	3,760
Total current liabilities	1,803,484	1,683,996	1,225,197
Long term debt	1,774,312	1,927,770	2,161,166
Long term operating lease liabilities	2,429,315	2,400,782	2,390,344
Other liabilities	105,737	103,940	113,580
Deferred tax liabilities	203,958	199,850	217,387
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value: authorized: 50,000,000 shares; no shares issued and outstanding
Common stock, $0.0001 par value: Authorized: 500,000,000 shares; Issued: 80,504,439 shares, 79,882,506 shares and 79,808,306 shares, respectively; Outstanding: 66,240,152 shares, 65,929,972 shares and 66,249,941 shares, respectively	7	7	7
Additional paid-in-capital	1,742,874	1,809,831	1,770,091
Accumulated earnings (deficit)	279,037	(11,702)	(175,712)
Accumulated other comprehensive loss	(22,595)	(23,015)	(27,394)
Treasury stock, at cost	(1,323,628)	(1,310,367)	(1,304,732)
Total stockholders' equity	675,695	464,754	262,260
Total liabilities and stockholders' equity	$ 6,992,501	$ 6,781,092	$ 6,369,934

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Statement Of Financial Position [Abstract]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	50,000,000	50,000,000	50,000,000
Preferred Stock, Issued	0	0	0
Preferred Stock, Outstanding	0	0	0
Common Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	81,041,969	80,661,453	80,414,151
Common Stock, Shares Outstanding	66,724,476	66,386,331	66,163,573

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020
OPERATING ACTIVITIES
Net income (loss)		$ 273,584	$ (380,509)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Depreciation and amortization		118,424	108,694
Impairment charges—long-lived assets		1,747	3,001
Amortization of deferred financing costs		3,100	1,786
Accretion of long term debt instruments		411	9,146
Deferred income taxes		42,434	(5,923)
Loss on extinguishment of debt		31,395	202
Non-cash stock compensation expense	[1]	36,059	30,045
Non-cash lease expense		(6,968)	1,226
Cash received from landlord allowances		19,995	12,825
Changes in assets and liabilities:
Accounts receivable		(15,631)	59,304
Merchandise inventories		(87,364)	169,694
Prepaid and other current assets		(89,449)	(13,553)
Accounts payable		116,346	(269,750)
Other current liabilities		(25,875)	10,131
Other long term assets and long term liabilities		1,087	(216,888)
Other operating activities		7,575	7,539
Net cash provided by (used in) operating activities		426,870	(473,030)
INVESTING ACTIVITIES
Cash paid for property and equipment		(147,187)	(133,722)
Lease acquisition costs		(436)
Proceeds from sale of property and equipment and assets held for sale		5,988
Other investing activities			(395)
Net cash (used in) investing activities		(141,635)	(134,117)
FINANCING ACTIVITIES
Proceeds from long term debt—Convertible Note			805,000
Proceeds from long term debt—Secured Note			300,000
Principal payments on long term debt—Secured Note		(323,866)
Purchase of treasury shares		(13,261)	(59,891)
Proceeds from stock option exercises		28,900	20,984
Deferred financing costs		(510)	(28,815)
Other financing activities		(7,649)	(6,059)
Net cash (used in) provided by financing activities		(321,193)	1,281,219
(Decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents		(35,958)	674,072
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period		1,386,858	409,656
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period		1,350,900	1,083,728
Supplemental disclosure of cash flow information:
Interest paid		32,719	17,722
Income tax payments - net		100,269	8,754
Non-cash investing activities:
Accrued purchases of property and equipment		43,207	60,693
ABL senior secured revolving facility
FINANCING ACTIVITIES
Proceeds from long term debt			400,000
Principal payments on long term debt			$ (150,000)
Senior Secured Term B-6 Loans
FINANCING ACTIVITIES
Proceeds from long term debt		956,608
Senior Secured Term B-5 Loans
FINANCING ACTIVITIES
Principal payments on long term debt		$ (961,415)
[1]	The amounts presented in the table above exclude taxes. For the three and six month periods ended July 31, 2021, the tax benefit related to the Company’s non-cash stock compensation was approximately $3.7 million and $6.1 million, respectively. For the three and six month periods ended August 1, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.2 million and $6.0 million, respectively.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Basis of Presentation As of July 31, 2021, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 792 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 2021 (Fiscal 2020 10-K). The balance sheet at January 30, 2021 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2020 10-K. Because of the COVID-19 pandemic discussed below, and because the Company’s business is seasonal in nature, the operating results for the three and six month periods ended July 31, 2021 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2020 10-K. Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 29, 2022 (Fiscal 2021) and the prior fiscal year ended January 30, 2021 (Fiscal 2020) both consist of 52 weeks. COVID-19 On March 11, 2020, the World Health Organization declared the novel coronavirus (known as COVID-19) outbreak to be a global pandemic. As a result, the Company began the temporary closing of some of its stores, and effective March 22, 2020, it made the decision to temporarily close all of its stores, distribution centers (other than processing of received inventory) and corporate offices to combat the rapid spread of COVID-19. These developments caused significant disruptions to the Company’s business and had a significant adverse impact on its financial condition, results of operations and cash flows. In response to the COVID-19 pandemic and the temporary closing of stores, the Company provided two weeks of financial support to associates impacted by these store closures and by the shutdown of distribution centers. The Company temporarily furloughed most store and distribution center associates, as well as some corporate associates, but continued to provide benefits to its furloughed associates in accordance with its benefit plans. In addition, the Company paid 100% of their medical benefit premiums during the period they were furloughed. During the second quarter of Fiscal 2020, the Company recalled all furloughed associates at its re-opened stores, as well as its corporate and distribution facilities. In order to maintain maximum financial flexibility during these uncertain times, the Company completed several debt transactions in the first quarter of Fiscal 2020. In March 2020, the Company borrowed $400 million on its existing $600 million senior secured asset-based revolving credit facility (the ABL Line of Credit), of which $150 million was repaid during the second quarter of Fiscal 2020, and the remaining $250 million was repaid during the fourth quarter of Fiscal 2020. In April 2020, the Company issued $805 million of 2.25% Convertible Senior Notes due 2025 (the Convertible Notes), and BCFWC issued $300 million of 6.25% Senior Secured Notes due 2025 (the Secured Notes). The Secured Notes were redeemed in full during the second quarter of Fiscal 2021. Refer to Note 4, “Long Term Debt,” for further discussion regarding these debt transactions. Additionally, the Company took the following steps to further enhance its financial flexibility: • Carefully managed operating expenses, working capital and capital expenditures, including ceasing substantially all buying activities while stores were closed. The Company subsequently resumed its buying activities, while continuing its conservative approach toward operating expenses and capital expenditures. • Negotiated rent deferral agreements with landlords. • Temporarily suspended the Company’s share repurchase program. • The Company’s CEO voluntarily agreed to not take a salary; the Company’s board of directors voluntarily forfeited their cash compensation; the Company’s executive leadership team voluntarily agreed to decrease their salary by 50%; and smaller salary reductions were temporarily put in place for all employees through a certain level. This compensation was reinstated once substantially all of the Company’s stores re-opened. • The annual incentive bonus payments related to Fiscal 2019 performance were delayed to the second quarter of Fiscal 2020, and merit pay increases for Fiscal 2020 were delayed to the third quarter of Fiscal 2020. Due to the aging of inventory related to the temporary store closures discussed above, as well as the impact of seasonality on the Company’s merchandise, the Company recognized inventory markdown reserves of $271.9 million during the three month period ended May 2, 2020. These reserves covered markdowns taken during the second quarter of Fiscal 2020. These charges were included in “Cost of sales” on the Company’s Condensed Consolidated Statement of Income (Loss). On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was signed into law, which provides emergency economic assistance for American workers, families and businesses affected by the COVID-19 pandemic. For the year ended January 30, 2021, the Company will obtain a one-time tax refund of $245.5 million from the carryback of federal net operating losses (NOLs) as a result of the CARES Act, which is included in the line item “Prepaid and other current assets” on the Company’s Condensed Consolidated Balance Sheet. Recently Adopted Accounting Standards Convertible Debt On August 5, 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The new guidance removes from GAAP the separation models for convertible debt with a cash conversion feature. The Company elected to early adopt this ASU as of the beginning of Fiscal 2021, using the modified retrospective method of transition. Prior periods have not been restated. As a result of adopting the guidance, the Company is no longer separating the Convertible Notes into debt and equity components, and is instead accounting for it wholly as debt. As of the beginning of Fiscal 2021, this ASU resulted in a reduction in the line item “Additional paid-in capital” of $176.0 million, net of deferred financing costs, and an increase in the line item “Long term debt” of $ The changes noted above caused a decrease in the effective interest rate on the Convertible Notes from 8.2% to 2.8%, resulting in a cumulative-effect adjustment to retained earnings of $23.0 million related to Fiscal 2020 interest expense, as well as a $7.7 million and $15.3 million reduction in interest expense for the three and six month periods ended July 31, 2021, respectively. As of the beginning of Fiscal 2021, the tax effect of adopting this guidance resulted in a $44.1 million increase in the line item “Additional paid-in-capital,” a $38.3 million reduction in the line item “Deferred tax liabilities” and a $5.9 million reduction to retained earnings. The new guidance also requires use of the if-converted method when calculating the dilutive impact of the Convertible Notes on earnings per share. The Company used the treasury stock method prior to adoption of the ASU. The impact of this ASU on net income and weighted average diluted shares resulted in an increase to diluted net income per share of $0.07 and $0.12 during the three and six month periods ended July 31, 2021, respectively. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and six month periods ended July 31, 2021, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of July 31, 2021 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
	Jul. 31, 2021
Stockholders Equity Note [Abstract]
Stockholders’ Equity	2. Stockholders’ Equity Activity for the three and six month periods ended July 31, 2021 and August 1, 2020 in the Company’s stockholders’ equity are summarized below: (in thousands, except share data) Common Stock Additional Paid-in Accumulated Earnings Accumulated Other Comprehensive Treasury Stock Shares Amount Capital (Deficit) Loss Shares Amount Total Balance at January 30, 2021 80,661,453 $ 7 $ 1,809,831 $ (11,702 ) $ (23,015 ) (14,275,122 ) $ (1,310,367 ) $ 464,754 Net income — — — 171,030 — — — 171,030 Stock options exercised 181,683 — 16,089 — — — — 16,089 Shares used for tax withholding — — — — — (41,768 ) (13,083 ) (13,083 ) Vesting of restricted shares, net of forfeitures of 883 restricted shares 53,914 — — — — — — — Stock based compensation — — 12,879 — — — — 12,879 Unrealized losses on interest rate derivative contracts, net of related taxes of $0.3 million — — — — 825 — — 825 Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,159 — — 2,159 Adoption of ASU 2020-06 (Note 1) — — (131,916 ) 17,155 — — — (114,761 ) Balance at May 1, 2021 80,897,050 7 1,706,883 176,483 (20,031 ) (14,316,890 ) (1,323,450 ) 539,892 Net income — — — 102,554 — — — 102,554 Stock options exercised 139,274 — 12,811 — — — — 12,811 Shares used for tax withholding — — — — — (603 ) (178 ) (178 ) Vesting of restricted shares, net of forfeitures of 1,101 restricted shares 5,645 — — — — — — — Stock based compensation — — 23,180 — — — — 23,180 Unrealized losses on interest rate derivative contracts, net of related taxes of $1.9 million — — — — (5,083 ) — — (5,083 ) Amount reclassified into earnings, net of related taxes of $0.9 million — — — — 2,519 — — 2,519 Balance at July 31, 2021 81,041,969 $ 7 $ 1,742,874 $ 279,037 $ (22,595 ) (14,317,493 ) $ (1,323,628 ) $ 675,695 (in thousands, except share data) Common Stock Additional Paid-in Accumulated Accumulated Other Comprehensive Treasury Stock Shares Amount Capital Deficit Loss Shares Amount Total Balance at February 1, 2020 79,882,506 $ 7 $ 1,587,146 $ 204,797 $ (18,960 ) (13,952,534 ) $ (1,244,841 ) $ 528,149 Net loss — — — (333,728 ) — — — (333,728 ) Stock options exercised 180,950 — 1,454 — — — — 1,454 Shares used for tax withholding — — — — — (41,363 ) (7,383 ) (7,383 ) Shares purchased as part of publicly announced programs — — — — — (243,573 ) (50,158 ) (50,158 ) Vesting of restricted shares, net of forfeitures of 4,166 restricted shares 20,715 — — — — — — — Stock based compensation — — 17,352 — — — — 17,352 Equity component of convertible notes issuance, net of related taxes of $44.1 million — — 131,916 — — — — 131,916 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $3.6 million — — — — (9,609 ) — — (9,609 ) Amount reclassified into earnings, net of related taxes of $0.4 million — — — — 1,108 — — 1,108 Balance at May 2, 2020 80,084,171 $ 7 $ 1,737,868 $ (128,931 ) $ (27,461 ) (14,237,470 ) $ (1,302,382 ) $ 279,101 Net loss — — — (46,781 ) — — — (46,781 ) Stock options exercised 324,500 — 19,530 — — — — 19,530 Shares used for tax withholding — — — — — (13,108 ) (2,350 ) (2,350 ) Vesting of restricted shares, net of forfeitures of 2,499 restricted shares 5,480 — — — — — — — Stock based compensation — — 12,693 — — — — 12,693 Unrealized losses on interest rate derivative contracts, net of related taxes of $0.7 million — — — — (1,982 ) — — (1,982 ) Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,049 — — 2,049 Balance at August 1, 2020 80,414,151 7 1,770,091 (175,712 ) (27,394 ) (14,250,578 ) (1,304,732 ) 262,260

Lease Commitments

Lease Commitments	6 Months Ended
	Jul. 31, 2021
Leases [Abstract]
Lease Commitments	3. Lease Commitments The Company’s leases primarily consist of stores, distribution facilities and office space under operating and finance leases that will expire principally during the next 30 years. The leases typically include renewal options at five year intervals and escalation clauses. Lease renewals are only included in the lease liability to the extent that they are reasonably assured of being exercised. The Company’s leases typically provide for contingent rentals based on a percentage of gross sales. Contingent rentals are not included in the lease liability, and they are recognized as variable lease cost when incurred. As a result of the COVID-19 pandemic and the associated temporary store closures discussed above, the Company worked with landlords to modify payment terms for certain leases. The FASB has provided relief under ASC 842, “Leases,” related to the COVID-19 pandemic. Under this relief, companies can make a policy election on how to treat lease concessions resulting directly from COVID-19, provided that the modified contracts result in total cash flows that are substantially the same or less than the cash flows in the original contract. The Company has made the policy election to account for lease concessions that result from the COVID-19 pandemic as if they were made as enforceable rights under the original contract. Additionally, the Company has elected to account for these concessions outside of the lease modification framework described under ASC 842. As a result, deferred payments related to these leases of $11.6 million are included in the line item “Other current liabilities” on the Company’s Condensed Consolidated Balance Sheet. Due dates for these payments vary by lease, with all payments due before the end of Fiscal 2021. The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Leases Finance Leases 2021 (remainder) $ 226,021 $ 3,693 2022 472,683 7,513 2023 449,112 7,589 2024 414,152 7,417 2025 380,927 5,287 2026 342,129 5,324 Thereafter 1,121,958 28,014 Total future minimum lease payments 3,406,982 64,837 Amount representing interest (651,385 ) (18,727 ) Total lease liabilities 2,755,597 46,110 Less: current portion of lease liabilities (326,282 ) (4,481 ) Total long term lease liabilities $ 2,429,315 $ 41,629 Weighted average discount rate 5.2 % 6.8 % Weighted average remaining lease term (years) 8.2 11.4 The above schedule excludes approximately $494.0 million for 96 stores that the Company has committed to open or relocate but has not yet taken possession of the space. The discount rates used in valuing the Company’s leases are not readily determinable, and are based on the Company’s incremental borrowing rate on a fully collateralized basis. The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Six Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Finance lease cost: Amortization of finance lease asset (a) $ 1,132 $ 1,211 $ 2,274 $ 2,422 Interest on lease liabilities (b) 790 857 1,598 1,729 Operating lease cost (c) 115,771 109,592 226,930 218,565 Variable lease cost (c) 46,165 45,643 92,912 86,861 Total lease cost 163,858 157,303 323,714 309,577 Less all rental income (d) (1,354 ) (1,265 ) (2,629 ) (2,513 ) Total net rent expense (e) $ 162,504 $ 156,038 $ 321,085 $ 307,064 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss). (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss). (e) Excludes an immaterial amount of short-term lease cost. Supplemental cash flow disclosures related to leases are as follows: (in thousands) Six Months Ended July 31, 2021 August 1, 2020 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 242,905 $ 169,391 Cash payments for the principal portion of finance lease liabilities (b) $ 1,908 $ 1,743 Cash payments for the interest portion of finance lease liabilities (a) $ 1,598 $ 1,729 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 203,396 $ 228,344 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt

Long Term Debt	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Long Term Debt	4. Long Term Debt Long term debt consists of: (in thousands) July 31, January 30, August 1, 2021 2021 2020 Senior secured term loan facility (Term B-6 Loans), LIBOR (with a floor of 0.00%) plus 2.00%, matures on June 24, 2028 $ 955,005 $ — $ — Senior secured term loan facility (Term B-5 Loans), LIBOR (with a floor of 0.00%) plus 1.75%, repaid in full on June 24, 2021 — 958,418 958,025 $805,000 convertible senior notes, 2.25%, matures on April 15, 2025 805,000 648,311 633,076 $300,000 senior secured notes, 6.25%, redeemed in full on June 11, 2021 — 300,000 300,000 $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures on June 29, 2023 — — 250,000 Finance lease obligations 46,110 47,664 48,848 Unamortized deferred financing costs (17,708 ) (22,724 ) (25,023 ) Total debt 1,788,407 1,931,669 2,164,926 Less: current maturities (14,095 ) (3,899 ) (3,760 ) Long term debt, net of current maturities $ 1,774,312 $ 1,927,770 $ 2,161,166 Term Loan Facility On February 26, 2020, BCFWC entered into Amendment No. 8 (the Eighth Amendment) to the Term Loan Credit Agreement governing its senior secured credit term loan facility (the Term Loan Facility). The Eighth Amendment, among other things, reduced the interest rate margins applicable to the Term Loan Facility from 1.00% to 0.75%, in the case of prime rate loans, and from 2.00% to 1.75%, in the case of LIBOR loans, with the LIBOR floor remaining at 0.00%. In connection with the execution of the Eighth Amendment, the Company incurred fees of $1.1 million, primarily related to legal and placement fees, which were recorded in the line item “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). Additionally, the Company recognized a non-cash loss on the extinguishment of debt of $0.2 million, representing the write-off of unamortized deferred financing costs and original issue discount, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statement of Income (Loss). On June 24, 2021, BCFWC entered into Amendment No. 9 (the Ninth Amendment) to the Term Loan Credit Agreement governing the Term Loan Facility. The Ninth Amendment, among other things, extended the maturity date from November 17, 2024 to June 24, 2028, and changed the interest rate margins applicable to the Term Loan Facility from 0.75% to 1.00%, in the case of prime rate loans, and from 1.75% to 2.00%, in the case of LIBOR loans, with a 0.00% LIBOR floor. This amendment also requires quarterly principal payments of $2.4 million. In connection with the execution of the Ninth Amendment, the Company incurred fees of $3.3 million, primarily related to legal and placement fees, which were recorded in the line item “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). Additionally, the Company recognized a loss on the extinguishment of debt of $1.2 million, representing the write-off of unamortized deferred financing costs and original issue discount, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statement of Income (Loss). At July 31, 2021 and August 1, 2020, the interest rate related to the Term Loan Facility was 2.1 Convertible Notes On April 16, 2020, the Company issued $805 million of Convertible Notes. An aggregate of up to 3,656,149 shares of common stock may be issued upon conversion of the Convertible Notes, which number is subject to adjustment up to an aggregate of 4,844,410 shares following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, and which is also subject to certain anti-dilution adjustments. The Convertible Notes are general unsecured obligations of the Company. The Convertible Notes bear interest at a rate of 2.25% per year, payable semi-annually in cash, in arrears, on April 15 and October 15 of each year, beginning on October 15, 2020. The Convertible Notes will mature on April 15, 2025, unless earlier converted, redeemed or repurchased. Prior to the close of business on the business day immediately preceding January 15, 2025, the Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Convertible Notes have an initial conversion rate of 4.5418 shares per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $220.18 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50% over $166.17 per share, the last reported sale price of the Company’s common stock on April 13, 2020 (the pricing date of the offering) on the New York Stock Exchange. During the first quarter of Fiscal 2021, the Company made an irrevocable settlement election for any conversions of the Convertible Notes. Upon conversion, the Company will pay cash for the principal amount. For any excess above principal, the Company will deliver shares of its common stock. The Company may not redeem the Convertible Notes prior to April 15, 2023. On or after April 15, 2023, the Company will be able to redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130% of the conversion price for a specified period of time, at a redemption price equal to 100% of the principal aggregate amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Holders of the Convertible Notes may require the Company to repurchase their Convertible Notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the Convertible Notes at a purchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their Convertible Notes in connection with such corporate event or during the relevant redemption period for such Convertible Notes. The Convertible Notes contain a cash conversion feature, and as a result, the Company initially separated it into liability and equity components. The Company valued the liability component based on its borrowing rate for a similar debt instrument that does not contain a conversion feature. The equity component, which was recognized as a debt discount, was valued as the difference between the face value of the Convertible Notes and the fair value of the liability component. As a result of adopting ASU 2020-06, the Company is no longer separating the Convertible Notes into debt and equity components, and is instead accounting for it wholly as debt. In connection with the Convertible Notes issuance, the Company incurred deferred financing costs of $21.0 million, primarily related to fees paid to the bookrunners of the offering, as well as legal, accounting and rating agency fees. These costs were initially allocated on a pro rata basis, with $16.4 million allocated to the debt component and $4.6 million allocated to the equity component. As a result of adopting ASU 2020-06, all unamortized deferred financing costs related to the Convertible Notes are now allocated to debt. Prior to adoption of ASU 2020-06, the debt discount and the debt portion of the deferred costs were being amortized to interest expense over the term of the Convertible Notes at an effective interest rate of 8.2%. The effective interest rate after adoption of ASU 2020-06 is 2.8%. The Convertible Notes consist of the following components as of the dates indicated: (in thousands) July 31, January 30, August 1, 2021 2021 2020 Liability component: Principal $ 805,000 $ 805,000 $ 805,000 Unamortized debt discount — (156,689 ) (171,924 ) Unamortized deferred debt costs (15,846 ) (14,191 ) (15,571 ) Net carrying amount $ 789,154 $ 634,120 $ 617,505 Equity component, net $ — $ 131,916 $ 131,916 Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Six Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Coupon interest $ 4,510 $ 4,513 $ 9,021 $ 5,356 Amortization of debt discount — 7,387 — 8,753 Amortization of deferred debt costs 1,007 672 2,007 793 Convertible Notes interest expense $ 5,517 $ 12,572 $ 11,028 $ 14,902 Secured Notes On April 16, 2020, BCFWC issued $300 million of Secured Notes. The Secured Notes were senior, secured obligations of BCFWC, and interest was payable semiannually in cash, in arrears, at a rate of 6.25% per annum on April 15 and October 15 of each year, beginning on October 15, 2020. The Secured Notes were guaranteed on a senior secured basis by Burlington Coat Factory Holdings, LLC, Burlington Coat Factory Investments Holdings, Inc. and BCFWC’s subsidiaries that guarantee the loans under the Term Loan Facility. In connection with the Secured Notes issuance, the Company incurred deferred financing costs of $7.9 million, primarily related to fees paid to the bookrunners of the offering, as well as legal fees. These costs are being amortized to interest expense over the term of the Secured Notes. The Company incurred additional costs of $2.5 million, primarily related to legal fees, which are recorded in the line item, “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). On June 11, 2021, BCFWC redeemed the full $300.0 million aggregate principal amount of the Secured Notes. The redemption price of the Secured Notes was $323.7 million, plus accrued and unpaid interest to, but not including, the date of redemption. This redemption resulted in a pre-tax debt extinguishment charge of $30.2 million in the three month period ended July 31, 2021. ABL Line of Credit On March 17, 2020, the Company borrowed $400 million under the ABL Line of Credit as a precautionary measure in order to increase the Company’s cash position and facilitate financial flexibility in light of the uncertainty resulting from COVID-19. The Company repaid $150 million of this amount during the second quarter of Fiscal 2020, and the remaining $250.0 million during the fourth quarter of Fiscal 2020. At July 31, 2021, the Company had $533.6 million available under the ABL Line of Credit. There were no borrowings under the ABL Line of Credit during the three and six month periods ended July 31, 2021. At August 1, 2020, the Company had $120.4 million available under the ABL Line of Credit. The maximum borrowings under the ABL Line of Credit during the three and six month periods ended August 1, 2020 amounted to $400.0 million. Average borrowings during the three and six month periods ended August 1, 2020 amounted to $372.0 million and $289.3 million, respectively, at an average interest rate of 2.1% in both periods.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	6 Months Ended
	Jul. 31, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	5. Derivative Instruments and Hedging Activities The Company accounts for derivatives and hedging activities in accordance with ASC 815, “Derivatives and Hedging” (ASC 815). As required by ASC 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. In addition, to comply with the provisions of ASC 820, “Fair Value Measurements” (ASC 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with ASC 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting, because the Company has only one derivative. The Company classifies its derivative valuations in Level 2 of the fair value hierarchy. On December 17, 2018, the Company entered into an interest rate swap, which hedged $450 million of the variable rate exposure under the Term Loan Facility at a rate of 2.72%. On June 24, 2021, the Company terminated this previous interest rate swap, and entered into a new interest rate swap, which hedges $450 million of the variable rate exposure on the Term Loan Facility at a blended rate of 2.19%, and is designated as a cash flow hedge. The amount of loss deferred for the previous interest rate swap was $ 26.9 million. The Company is amortizing this amount from accumulated other comprehensive loss into interest expense over the original life of the previous interest rate swap, which had an original maturity date of December 29, 2023 . The new interest rate swap had a liability fair va lue at inception of $ 26.9 million. The Company will accrete this amount into accumulated other comprehensive loss as a benefit to interest expense over the life of the new interest rate swap, which has a maturity date of June 24, 2028 . Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of July 31, 2021, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Instruments Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.19% June 24, 2028 Tabular Disclosure The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments July 31, 2021 January 30, 2021 August 1, 2020 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate swap contracts Other liabilities $ 31,764 Other liabilities $ 31,665 Other liabilities $ 37,798 The following table presents the unrealized gains and losses deferred to accumulated other comprehensive loss resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Six Months Ended Interest Rate Derivatives: July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Unrealized losses, before taxes $ (6,972 ) $ (2,730 ) $ (5,840 ) $ (15,894 ) Income tax benefit 1,889 748 1,582 4,303 Unrealized losses, net of taxes $ (5,083 ) $ (1,982 ) $ (4,258 ) $ (11,591 ) The following table presents information about the reclassification of gains and losses from accumulated other comprehensive loss into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Six Months Ended Component of Earnings: July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Interest expense $ 3,459 $ 2,820 $ 6,423 $ 4,352 Income tax benefit (940 ) (771 ) (1,745 ) (1,195 ) Net reclassification into earnings $ 2,519 $ 2,049 $ 4,678 $ 3,157 The Company estimates that approximately $6.7 million will be reclassified from accumulated other comprehensive loss into interest expense during the next twelve months.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	6. Fair Value Measurements The Company accounts for fair value measurements in accordance with Topic No. 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. Topic No. 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets. Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities. The inputs into the determination of fair value require significant management judgment or estimation. The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. Refer to Note 5, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate swap contract. Financial Assets The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of July 31, 2021, January 30, 2021 and August 1, 2020 are summarized below: (in thousands) Fair Value Measurements at July 31, January 30, August 1, 2021 2021 2020 Level 1 Cash equivalents (including restricted cash) $ 701,577 $ 1,001,475 $ 1,001,253 Long-Lived Assets Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of ASC 820. The fair value of the Company’s long-lived assets is generally calculated using discounted cash flows. During the three and six months ended July 31, 2021, the Company recorded impairment charges of $1.0 million and $1.7 million, respectively, primarily related to the expected sale of one store, as well as declines in revenues and operating results for one store. These costs were recorded in the line item “Impairment charges – long-lived assets” in the Company’s Condensed Consolidated Statements of Income (Loss). The assets associated with the sale had a remaining fair value as of July 31, 2021 of $2.5 million, and would be categorized as Level 2 in the fair value hierarchy described above. Financial Liabilities The fair values of the Company’s financial liabilities are summarized below: (in thousands) July 31, 2021 January 30, 2021 August 1, 2020 Principal Amount Fair Value Principal Amount Fair Value Principal Amount Fair Value Term B-6 Loans $ 961,415 $ 954,204 $ — $ — $ — $ — Term B-5 Loans — — 961,415 955,406 961,415 914,546 Convertible Notes 805,000 1,319,733 805,000 1,080,713 805,000 896,070 Secured Notes — — 300,000 320,625 300,000 319,875 ABL Line of Credit (a) — — — — 250,000 250,000 Total debt (b) $ 1,766,415 $ 2,273,937 $ 2,066,415 $ 2,356,744 $ 2,316,415 $ 2,380,491 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs. The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy, and are based on current market quotes received from inactive markets.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	7. Income Taxes Income tax expense was $21.2 million during the second quarter of Fiscal 2021 compared with income tax benefit of $63.1 million during the second quarter of Fiscal 2020. The effective tax rate for the second quarter of Fiscal 2021 was 17.1% compared with 57.4% during the second quarter of Fiscal 2020. Income tax expense was $61.8 million during the six month period ended July 31, 2021, compared with income tax benefit of $268.4 million during the six month period ended August 1, 2020. The effective tax rate for the six month period ended July 31, 2021 was 18.4%, compared with 41.4% during the six month period ended August 1, 2020. The decrease in the effective tax rate was primarily due to the Company’s pretax loss in the prior year and applying various provisions of the CARES Act, namely the benefit related to the carryback of federal NOLs in Fiscal 2020 to earlier tax years with higher tax rates. Net deferred taxes are as follows: (in thousands) July 31, January 30, August 1, 2021 2021 2020 Deferred tax asset $ 4,197 $ 4,422 $ 4,678 Deferred tax liability 203,958 199,850 217,387 Net deferred tax liability $ 199,761 $ 195,428 $ 212,709 Net deferred tax assets relate to Puerto Rico deferred balances that have a future net benefit for tax purposes. Net deferred tax liabilities primarily relate to intangible assets and depreciation expense where the Company has a future obligation for tax purposes. As of July 31, 2021, the Company had a deferred tax asset related to net operating losses of $31.3 million, inclusive of $31.0 million related to state net operating losses that expire at various dates between 2022 and 2040, as well as $0.3 million related to Puerto Rico net operating losses that will expire in 2025. As of July 31, 2021, the Company had a deferred tax asset related to tax credit carry-forwards of $6.9 million, inclusive of $5.9 million of state tax credit carry-forwards, which will begin to expire in 2023, and $1.0 million of deferred tax assets recorded for Puerto Rico alternative minimum tax credits that have an indefinite life. As of July 31, 2021, January 30, 2021 and August 1, 2020, valuation allowances amounted to $11.3 million, $13.0 million and $11.5 million, respectively, related to state and Puerto Rico net operating losses and state tax credit carry-forwards. The Company believes that it is more likely than not that this portion of state and Puerto Rico net operating losses and state tax credit carry-forwards will not be realized.

Capital Stock

Capital Stock	6 Months Ended
	Jul. 31, 2021
Capital Stock [Abstract]
Capital Stock	8. Capital Stock Treasury Stock The Company accounts for treasury stock under the cost method. During the six month period ended July 31, 2021, the Company acquired 42,371 shares of common stock from employees for approximately $13.3 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock and restricted stock unit awards, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. Share Repurchase Program s On August 14, 2019, the Company’s Board of Directors authorized the repurchase of up to $400 million of common stock, which was authorized to be executed through August 2021. As part of the Company’s cash management efforts during the COVID-19 pandemic, the Company temporarily suspended its share repurchase programs in March 2020. As of July 31, 2021, the Company had $348.4 million remaining under this share repurchase authorization, which expired in August 2021 On August 18, 2021, the Company’s board of directors authorized the repurchase of up to $400 million of common stock, which is authorized to be executed through August 2023. The Company’s repurchase program is funded using the Company’s available cash and borrowings under the ABL Line of Credit.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	9. Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding. Diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares and potentially dilutive securities outstanding during the period using the treasury stock method for the Company’s stock option, restricted stock and restricted stock unit awards, and the if-converted method for the Convertible Notes. The following table presents the computation of basic and diluted net income (loss) per share: (in thousands, except per share data) Three Months Ended Six Months Ended July 31, August 1, July 31, August 1, 2021 2020 2021 2020 Basic net income (loss) per share Net income (loss) $ 102,554 $ (46,781 ) $ 273,584 $ (380,509 ) Weighted average number of common shares – basic 66,636 65,947 66,516 65,760 Net income (loss) per common share – basic $ 1.54 $ (0.71 ) $ 4.11 $ (5.79 ) Diluted net income (loss) per share Net income (loss) $ 102,554 $ (46,781 ) $ 273,584 $ (380,509 ) Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 66,636 65,947 66,516 65,760 Assumed exercise of stock options and vesting of restricted stock 660 — 711 — Assumed conversion of convertible debt 1,152 — 1,013 — Weighted average number of common shares – diluted 68,448 65,947 68,240 65,760 Net income (loss) per common share – diluted $ 1.50 $ (0.71 ) $ 4.01 $ (5.79 ) Approximately 185,000 and 95,000 shares of the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and six month periods ended July 31, 2021, respectively, since their effect was anti-dilutive. All of the Company’s stock option, restricted stock and restricted stock unit awards have an anti-dilutive effect while in a net loss position. Approximately 2,005,000 and 2,015,000 shares related to the Company’s stock option, restricted stock and restricted stock unit awards were excluded from diluted net loss per share for the three and six month periods ended August 1, 2020, respectively, since their effect was anti-dilutive.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jul. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	10. Stock-Based Compensation As of July 31, 2021, there were 1,994,299 shares of common stock available for issuance under the Company’s 2013 Omnibus Incentive Plan. Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Six Months Ended July 31, August 1, July 31, August 1, Type of Non-Cash Stock Compensation 2021 2020 2021 2020 Restricted stock and restricted stock unit grants (a) $ 7,684 $ 5,739 $ 13,940 $ 12,638 Stock option grants (a) 4,682 4,696 9,076 11,028 Performance stock unit grants (a) 10,814 2,258 13,043 6,379 Total (b) $ 23,180 $ 12,693 $ 36,059 $ 30,045 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) The amounts presented in the table above exclude taxes. For the three and six month periods ended July 31, 2021, the tax benefit related to the Company’s non-cash stock compensation was approximately $3.7 million and $6.1 million, respectively. For the three and six month periods ended August 1, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.2 million and $6.0 million, respectively. Stock Options Stock option transactions during the six month period ended July 31, 2021 are summarized as follows: Number of Shares Weighted Average Exercise Price Per Share Options outstanding, January 30, 2021 1,346,775 $ 133.86 Options granted 165,775 324.91 Options exercised (a) (320,957 ) 90.05 Options forfeited (32,324 ) 190.33 Options outstanding, July 31, 2021 1,159,269 $ 171.73 (a) Options exercised during the six month period ended July 31, 2021 had a total intrinsic value of $ 70.1 The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of July 31, 2021: Options Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Aggregate Intrinsic Value (in millions) Options vested and expected to vest 1,159,269 6.7 $ 171.73 $ 189.0 Options exercisable 529,381 4.9 $ 128.54 $ 109.2 The fair value of each stock option granted during the six month period ended July 31, 2021 was estimated using the Black Scholes option pricing model using the following assumptions: Six Months Ended July 31, 2021 Risk-free interest rate 0.45% - 1.13% Expected volatility 34% - 35% Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0% Weighted average grant date fair value of options issued $ 113.59 The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. Since the Company completed its initial public offering in October 2013, it does not have sufficient history as a publicly traded company to evaluate its volatility factor. As such, the expected stock price volatility is based upon the historical volatility of the stock price over the expected life of the options of peer companies that are publicly traded. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. For grants issued during the six month period ended July 31, 2021, the expected life of the options was calculated using the simplified method. The simplified method defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. This methodology was utilized due to the relatively short length of time the Company’s common stock has been publicly traded. Restricted Stock Prior to May 1, 2019, the Company granted shares of restricted stock. Grants made on and after May 1, 2019 are in the form of restricted stock units. Restricted stock transactions during the six month period ended July 31, 2021 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested awards outstanding, January 30, 2021 396,555 $ 168.87 Awards granted 120,945 324.83 Awards vested (a) (127,445 ) 145.26 Awards forfeited (14,442 ) 199.55 Non-vested awards outstanding, July 31, 2021 375,613 225.92 (a) Restricted stock awards vested during the six month period ended July 31, 2021 had a total intrinsic value of $40.2 million. The fair value of each share of restricted stock granted during Fiscal 2021 was based upon the closing price of the Company’s common stock on the grant date Performance Stock Units The Company grants performance-based restricted stock units to its senior executives. Vesting of these performance stock units is based on continued service and the achievement of pre-established EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over a three-year Performance stock unit transactions during the six month period ended July 31, 2021 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested units outstanding, January 30, 2021 148,668 $ 176.70 Units granted 50,044 324.28 Awards forfeited (16,011 ) 215.27 Non-vested units outstanding, July 31, 2021 182,701 213.74

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal Like many retailers, the Company has been named in potential class or collective actions on behalf of groups alleging violations of federal and state wage and hour and other labor statutes, and alleged violations of state consumer and/or privacy protection and other statutes. In the normal course of business, the Company is also party to representative claims under the California Private Attorneys’ General Act and various other lawsuits and regulatory proceedings including, among others, commercial, product, product safety, employee, customer, intellectual property and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. While no assurance can be given as to the ultimate outcome of these matters, the Company believes that the final resolution of these actions will not have a material adverse effect on the Company’s results of operations, financial position, liquidity or capital resources. Letters of Credit The Company had letters of credit arrangements with various banks in the aggregate amount of $65.3 million, $54.9 million and $53.9 million as of July 31, 2021, January 30, 2021 and August 1, 2020, respectively. Among these arrangements, as of July 31, 2021, January 30, 2021 and August 1, 2020, the Company had letters of credit outstanding in the amount of $46.7 million, $46.8 million and $47.2 million, respectively, guaranteeing performance under various insurance contracts and utility agreements. In addition, the Company had outstanding letters of credit arrangements in the amounts of $18.6 million, $8.2 million and $6.7 million at July 31, 2021, January 30, 2021 and August 1, 2020, respectively, related to certain merchandising agreements. Based on the terms of the agreement governing the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $533.6 million, $476.8 million and $120.4 million as of July 31, 2021, January 30, 2021 and August 1, 2020, respectively. Purchase Commitments The Company had $1,959.7 million of purchase commitments related to goods that were not received as of July 31, 2021. Death Benefits In November 2005, the Company entered into agreements with three of the Company’s former executives whereby upon each of their deaths the Company will pay $1.0 million to each respective designated beneficiary.

Related Parties

Related Parties	6 Months Ended
	Jul. 31, 2021
Related Party Transactions [Abstract]
Related Parties	12. Related Parties The brother-in-law of one of the Company’s former Executive Vice Presidents is an independent sales representative of one of the Company’s suppliers of merchandise inventory. This relationship predated the commencement of the former Executive Vice President’s employment with the Company. The Company has determined that the dollar amount of purchases through such supplier represents an insignificant amount of its inventory purchases. The Executive Vice President retired from the Company during the second quarter of Fiscal 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation As of July 31, 2021, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 792 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 2021 (Fiscal 2020 10-K). The balance sheet at January 30, 2021 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2020 10-K. Because of the COVID-19 pandemic discussed below, and because the Company’s business is seasonal in nature, the operating results for the three and six month periods ended July 31, 2021 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2020 10-K.
Fiscal Year	Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 29, 2022 (Fiscal 2021) and the prior fiscal year ended January 30, 2021 (Fiscal 2020) both consist of 52 weeks.
COVID-19	COVID-19 On March 11, 2020, the World Health Organization declared the novel coronavirus (known as COVID-19) outbreak to be a global pandemic. As a result, the Company began the temporary closing of some of its stores, and effective March 22, 2020, it made the decision to temporarily close all of its stores, distribution centers (other than processing of received inventory) and corporate offices to combat the rapid spread of COVID-19. These developments caused significant disruptions to the Company’s business and had a significant adverse impact on its financial condition, results of operations and cash flows. In response to the COVID-19 pandemic and the temporary closing of stores, the Company provided two weeks of financial support to associates impacted by these store closures and by the shutdown of distribution centers. The Company temporarily furloughed most store and distribution center associates, as well as some corporate associates, but continued to provide benefits to its furloughed associates in accordance with its benefit plans. In addition, the Company paid 100% of their medical benefit premiums during the period they were furloughed. During the second quarter of Fiscal 2020, the Company recalled all furloughed associates at its re-opened stores, as well as its corporate and distribution facilities. In order to maintain maximum financial flexibility during these uncertain times, the Company completed several debt transactions in the first quarter of Fiscal 2020. In March 2020, the Company borrowed $400 million on its existing $600 million senior secured asset-based revolving credit facility (the ABL Line of Credit), of which $150 million was repaid during the second quarter of Fiscal 2020, and the remaining $250 million was repaid during the fourth quarter of Fiscal 2020. In April 2020, the Company issued $805 million of 2.25% Convertible Senior Notes due 2025 (the Convertible Notes), and BCFWC issued $300 million of 6.25% Senior Secured Notes due 2025 (the Secured Notes). The Secured Notes were redeemed in full during the second quarter of Fiscal 2021. Refer to Note 4, “Long Term Debt,” for further discussion regarding these debt transactions. Additionally, the Company took the following steps to further enhance its financial flexibility: • Carefully managed operating expenses, working capital and capital expenditures, including ceasing substantially all buying activities while stores were closed. The Company subsequently resumed its buying activities, while continuing its conservative approach toward operating expenses and capital expenditures. • Negotiated rent deferral agreements with landlords. • Temporarily suspended the Company’s share repurchase program. • The Company’s CEO voluntarily agreed to not take a salary; the Company’s board of directors voluntarily forfeited their cash compensation; the Company’s executive leadership team voluntarily agreed to decrease their salary by 50%; and smaller salary reductions were temporarily put in place for all employees through a certain level. This compensation was reinstated once substantially all of the Company’s stores re-opened. • The annual incentive bonus payments related to Fiscal 2019 performance were delayed to the second quarter of Fiscal 2020, and merit pay increases for Fiscal 2020 were delayed to the third quarter of Fiscal 2020. Due to the aging of inventory related to the temporary store closures discussed above, as well as the impact of seasonality on the Company’s merchandise, the Company recognized inventory markdown reserves of $271.9 million during the three month period ended May 2, 2020. These reserves covered markdowns taken during the second quarter of Fiscal 2020. These charges were included in “Cost of sales” on the Company’s Condensed Consolidated Statement of Income (Loss). On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was signed into law, which provides emergency economic assistance for American workers, families and businesses affected by the COVID-19 pandemic. For the year ended January 30, 2021, the Company will obtain a one-time tax refund of $245.5 million from the carryback of federal net operating losses (NOLs) as a result of the CARES Act, which is included in the line item “Prepaid and other current assets” on the Company’s Condensed Consolidated Balance Sheet.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards Convertible Debt On August 5, 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The new guidance removes from GAAP the separation models for convertible debt with a cash conversion feature. The Company elected to early adopt this ASU as of the beginning of Fiscal 2021, using the modified retrospective method of transition. Prior periods have not been restated. As a result of adopting the guidance, the Company is no longer separating the Convertible Notes into debt and equity components, and is instead accounting for it wholly as debt. As of the beginning of Fiscal 2021, this ASU resulted in a reduction in the line item “Additional paid-in capital” of $176.0 million, net of deferred financing costs, and an increase in the line item “Long term debt” of $ The changes noted above caused a decrease in the effective interest rate on the Convertible Notes from 8.2% to 2.8%, resulting in a cumulative-effect adjustment to retained earnings of $23.0 million related to Fiscal 2020 interest expense, as well as a $7.7 million and $15.3 million reduction in interest expense for the three and six month periods ended July 31, 2021, respectively. As of the beginning of Fiscal 2021, the tax effect of adopting this guidance resulted in a $44.1 million increase in the line item “Additional paid-in-capital,” a $38.3 million reduction in the line item “Deferred tax liabilities” and a $5.9 million reduction to retained earnings. The new guidance also requires use of the if-converted method when calculating the dilutive impact of the Convertible Notes on earnings per share. The Company used the treasury stock method prior to adoption of the ASU. The impact of this ASU on net income and weighted average diluted shares resulted in an increase to diluted net income per share of $0.07 and $0.12 during the three and six month periods ended July 31, 2021, respectively. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and six month periods ended July 31, 2021, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of July 31, 2021 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
	Jul. 31, 2021
Stockholders Equity Note [Abstract]
Company's Stockholders Equity	Activity for the three and six month periods ended July 31, 2021 and August 1, 2020 in the Company’s stockholders’ equity are summarized below: (in thousands, except share data) Common Stock Additional Paid-in Accumulated Earnings Accumulated Other Comprehensive Treasury Stock Shares Amount Capital (Deficit) Loss Shares Amount Total Balance at January 30, 2021 80,661,453 $ 7 $ 1,809,831 $ (11,702 ) $ (23,015 ) (14,275,122 ) $ (1,310,367 ) $ 464,754 Net income — — — 171,030 — — — 171,030 Stock options exercised 181,683 — 16,089 — — — — 16,089 Shares used for tax withholding — — — — — (41,768 ) (13,083 ) (13,083 ) Vesting of restricted shares, net of forfeitures of 883 restricted shares 53,914 — — — — — — — Stock based compensation — — 12,879 — — — — 12,879 Unrealized losses on interest rate derivative contracts, net of related taxes of $0.3 million — — — — 825 — — 825 Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,159 — — 2,159 Adoption of ASU 2020-06 (Note 1) — — (131,916 ) 17,155 — — — (114,761 ) Balance at May 1, 2021 80,897,050 7 1,706,883 176,483 (20,031 ) (14,316,890 ) (1,323,450 ) 539,892 Net income — — — 102,554 — — — 102,554 Stock options exercised 139,274 — 12,811 — — — — 12,811 Shares used for tax withholding — — — — — (603 ) (178 ) (178 ) Vesting of restricted shares, net of forfeitures of 1,101 restricted shares 5,645 — — — — — — — Stock based compensation — — 23,180 — — — — 23,180 Unrealized losses on interest rate derivative contracts, net of related taxes of $1.9 million — — — — (5,083 ) — — (5,083 ) Amount reclassified into earnings, net of related taxes of $0.9 million — — — — 2,519 — — 2,519 Balance at July 31, 2021 81,041,969 $ 7 $ 1,742,874 $ 279,037 $ (22,595 ) (14,317,493 ) $ (1,323,628 ) $ 675,695 (in thousands, except share data) Common Stock Additional Paid-in Accumulated Accumulated Other Comprehensive Treasury Stock Shares Amount Capital Deficit Loss Shares Amount Total Balance at February 1, 2020 79,882,506 $ 7 $ 1,587,146 $ 204,797 $ (18,960 ) (13,952,534 ) $ (1,244,841 ) $ 528,149 Net loss — — — (333,728 ) — — — (333,728 ) Stock options exercised 180,950 — 1,454 — — — — 1,454 Shares used for tax withholding — — — — — (41,363 ) (7,383 ) (7,383 ) Shares purchased as part of publicly announced programs — — — — — (243,573 ) (50,158 ) (50,158 ) Vesting of restricted shares, net of forfeitures of 4,166 restricted shares 20,715 — — — — — — — Stock based compensation — — 17,352 — — — — 17,352 Equity component of convertible notes issuance, net of related taxes of $44.1 million — — 131,916 — — — — 131,916 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $3.6 million — — — — (9,609 ) — — (9,609 ) Amount reclassified into earnings, net of related taxes of $0.4 million — — — — 1,108 — — 1,108 Balance at May 2, 2020 80,084,171 $ 7 $ 1,737,868 $ (128,931 ) $ (27,461 ) (14,237,470 ) $ (1,302,382 ) $ 279,101 Net loss — — — (46,781 ) — — — (46,781 ) Stock options exercised 324,500 — 19,530 — — — — 19,530 Shares used for tax withholding — — — — — (13,108 ) (2,350 ) (2,350 ) Vesting of restricted shares, net of forfeitures of 2,499 restricted shares 5,480 — — — — — — — Stock based compensation — — 12,693 — — — — 12,693 Unrealized losses on interest rate derivative contracts, net of related taxes of $0.7 million — — — — (1,982 ) — — (1,982 ) Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,049 — — 2,049 Balance at August 1, 2020 80,414,151 7 1,770,091 (175,712 ) (27,394 ) (14,250,578 ) (1,304,732 ) 262,260

Lease Commitments (Tables)

Lease Commitments (Tables)	6 Months Ended
	Jul. 31, 2021
Leases [Abstract]
Future Lease Payments	The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Leases Finance Leases 2021 (remainder) $ 226,021 $ 3,693 2022 472,683 7,513 2023 449,112 7,589 2024 414,152 7,417 2025 380,927 5,287 2026 342,129 5,324 Thereafter 1,121,958 28,014 Total future minimum lease payments 3,406,982 64,837 Amount representing interest (651,385 ) (18,727 ) Total lease liabilities 2,755,597 46,110 Less: current portion of lease liabilities (326,282 ) (4,481 ) Total long term lease liabilities $ 2,429,315 $ 41,629 Weighted average discount rate 5.2 % 6.8 % Weighted average remaining lease term (years) 8.2 11.4
Schedule of Net Lease Costs	The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Six Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Finance lease cost: Amortization of finance lease asset (a) $ 1,132 $ 1,211 $ 2,274 $ 2,422 Interest on lease liabilities (b) 790 857 1,598 1,729 Operating lease cost (c) 115,771 109,592 226,930 218,565 Variable lease cost (c) 46,165 45,643 92,912 86,861 Total lease cost 163,858 157,303 323,714 309,577 Less all rental income (d) (1,354 ) (1,265 ) (2,629 ) (2,513 ) Total net rent expense (e) $ 162,504 $ 156,038 $ 321,085 $ 307,064 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss). (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss). (e) Excludes an immaterial amount of short-term lease cost.
Schedule of Supplemental Cash Flow Disclosures Related to Leases	Supplemental cash flow disclosures related to leases are as follows: (in thousands) Six Months Ended July 31, 2021 August 1, 2020 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 242,905 $ 169,391 Cash payments for the principal portion of finance lease liabilities (b) $ 1,908 $ 1,743 Cash payments for the interest portion of finance lease liabilities (a) $ 1,598 $ 1,729 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 203,396 $ 228,344 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt (Tables)

Long Term Debt (Tables)	6 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Long Term Debt	Long term debt consists of: (in thousands) July 31, January 30, August 1, 2021 2021 2020 Senior secured term loan facility (Term B-6 Loans), LIBOR (with a floor of 0.00%) plus 2.00%, matures on June 24, 2028 $ 955,005 $ — $ — Senior secured term loan facility (Term B-5 Loans), LIBOR (with a floor of 0.00%) plus 1.75%, repaid in full on June 24, 2021 — 958,418 958,025 $805,000 convertible senior notes, 2.25%, matures on April 15, 2025 805,000 648,311 633,076 $300,000 senior secured notes, 6.25%, redeemed in full on June 11, 2021 — 300,000 300,000 $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures on June 29, 2023 — — 250,000 Finance lease obligations 46,110 47,664 48,848 Unamortized deferred financing costs (17,708 ) (22,724 ) (25,023 ) Total debt 1,788,407 1,931,669 2,164,926 Less: current maturities (14,095 ) (3,899 ) (3,760 ) Long term debt, net of current maturities $ 1,774,312 $ 1,927,770 $ 2,161,166
Schedule of Components of Convertible Notes	The Convertible Notes consist of the following components as of the dates indicated: (in thousands) July 31, January 30, August 1, 2021 2021 2020 Liability component: Principal $ 805,000 $ 805,000 $ 805,000 Unamortized debt discount — (156,689 ) (171,924 ) Unamortized deferred debt costs (15,846 ) (14,191 ) (15,571 ) Net carrying amount $ 789,154 $ 634,120 $ 617,505 Equity component, net $ — $ 131,916 $ 131,916
Schedule of Interest Expense Related to Convertible Notes	Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Six Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Coupon interest $ 4,510 $ 4,513 $ 9,021 $ 5,356 Amortization of debt discount — 7,387 — 8,753 Amortization of deferred debt costs 1,007 672 2,007 793 Convertible Notes interest expense $ 5,517 $ 12,572 $ 11,028 $ 14,902

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	6 Months Ended
	Jul. 31, 2021
Fair Value of Company's Derivative Financial Instruments on Gross Basis as well as Classification	The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments July 31, 2021 January 30, 2021 August 1, 2020 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate swap contracts Other liabilities $ 31,764 Other liabilities $ 31,665 Other liabilities $ 37,798
Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Loss	The following table presents the unrealized gains and losses deferred to accumulated other comprehensive loss resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Six Months Ended Interest Rate Derivatives: July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Unrealized losses, before taxes $ (6,972 ) $ (2,730 ) $ (5,840 ) $ (15,894 ) Income tax benefit 1,889 748 1,582 4,303 Unrealized losses, net of taxes $ (5,083 ) $ (1,982 ) $ (4,258 ) $ (11,591 )
Reclassification of Gains and Losses from Accumulated Other Comprehensive Loss into Earnings	The following table presents information about the reclassification of gains and losses from accumulated other comprehensive loss into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Six Months Ended Component of Earnings: July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Interest expense $ 3,459 $ 2,820 $ 6,423 $ 4,352 Income tax benefit (940 ) (771 ) (1,745 ) (1,195 ) Net reclassification into earnings $ 2,519 $ 2,049 $ 4,678 $ 3,157
Derivatives Designated as Hedging Instruments
Outstanding Interest Rate Derivative in Qualifying Hedging Relationships	As of July 31, 2021, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Instruments Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.19% June 24, 2028

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Fair Values of Financial Assets and Hierarchy of Level of Inputs	The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of July 31, 2021, January 30, 2021 and August 1, 2020 are summarized below: (in thousands) Fair Value Measurements at July 31, January 30, August 1, 2021 2021 2020 Level 1 Cash equivalents (including restricted cash) $ 701,577 $ 1,001,475 $ 1,001,253
Fair Values of Financial Liabilities	The fair values of the Company’s financial liabilities are summarized below: (in thousands) July 31, 2021 January 30, 2021 August 1, 2020 Principal Amount Fair Value Principal Amount Fair Value Principal Amount Fair Value Term B-6 Loans $ 961,415 $ 954,204 $ — $ — $ — $ — Term B-5 Loans — — 961,415 955,406 961,415 914,546 Convertible Notes 805,000 1,319,733 805,000 1,080,713 805,000 896,070 Secured Notes — — 300,000 320,625 300,000 319,875 ABL Line of Credit (a) — — — — 250,000 250,000 Total debt (b) $ 1,766,415 $ 2,273,937 $ 2,066,415 $ 2,356,744 $ 2,316,415 $ 2,380,491 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Net Deferred Taxes	Net deferred taxes are as follows: (in thousands) July 31, January 30, August 1, 2021 2021 2020 Deferred tax asset $ 4,197 $ 4,422 $ 4,678 Deferred tax liability 203,958 199,850 217,387 Net deferred tax liability $ 199,761 $ 195,428 $ 212,709

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	6 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Income (Loss) per Share	The following table presents the computation of basic and diluted net income (loss) per share: (in thousands, except per share data) Three Months Ended Six Months Ended July 31, August 1, July 31, August 1, 2021 2020 2021 2020 Basic net income (loss) per share Net income (loss) $ 102,554 $ (46,781 ) $ 273,584 $ (380,509 ) Weighted average number of common shares – basic 66,636 65,947 66,516 65,760 Net income (loss) per common share – basic $ 1.54 $ (0.71 ) $ 4.11 $ (5.79 ) Diluted net income (loss) per share Net income (loss) $ 102,554 $ (46,781 ) $ 273,584 $ (380,509 ) Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 66,636 65,947 66,516 65,760 Assumed exercise of stock options and vesting of restricted stock 660 — 711 — Assumed conversion of convertible debt 1,152 — 1,013 — Weighted average number of common shares – diluted 68,448 65,947 68,240 65,760 Net income (loss) per common share – diluted $ 1.50 $ (0.71 ) $ 4.01 $ (5.79 )

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jul. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation Expense	Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Six Months Ended July 31, August 1, July 31, August 1, Type of Non-Cash Stock Compensation 2021 2020 2021 2020 Restricted stock and restricted stock unit grants (a) $ 7,684 $ 5,739 $ 13,940 $ 12,638 Stock option grants (a) 4,682 4,696 9,076 11,028 Performance stock unit grants (a) 10,814 2,258 13,043 6,379 Total (b) $ 23,180 $ 12,693 $ 36,059 $ 30,045 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) The amounts presented in the table above exclude taxes. For the three and six month periods ended July 31, 2021, the tax benefit related to the Company’s non-cash stock compensation was approximately $3.7 million and $6.1 million, respectively. For the three and six month periods ended August 1, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.2 million and $6.0 million, respectively.
Stock Option Transactions	Stock option transactions during the six month period ended July 31, 2021 are summarized as follows: Number of Shares Weighted Average Exercise Price Per Share Options outstanding, January 30, 2021 1,346,775 $ 133.86 Options granted 165,775 324.91 Options exercised (a) (320,957 ) 90.05 Options forfeited (32,324 ) 190.33 Options outstanding, July 31, 2021 1,159,269 $ 171.73 (a) Options exercised during the six month period ended July 31, 2021 had a total intrinsic value of $ 70.1
Stock Options Vested and Expected to Vest	The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of July 31, 2021: Options Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Aggregate Intrinsic Value (in millions) Options vested and expected to vest 1,159,269 6.7 $ 171.73 $ 189.0 Options exercisable 529,381 4.9 $ 128.54 $ 109.2
Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted	The fair value of each stock option granted during the six month period ended July 31, 2021 was estimated using the Black Scholes option pricing model using the following assumptions: Six Months Ended July 31, 2021 Risk-free interest rate 0.45% - 1.13% Expected volatility 34% - 35% Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0% Weighted average grant date fair value of options issued $ 113.59
Award Grant and Vesting Transactions	Restricted stock transactions during the six month period ended July 31, 2021 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested awards outstanding, January 30, 2021 396,555 $ 168.87 Awards granted 120,945 324.83 Awards vested (a) (127,445 ) 145.26 Awards forfeited (14,442 ) 199.55 Non-vested awards outstanding, July 31, 2021 375,613 225.92 (a) Restricted stock awards vested during the six month period ended July 31, 2021 had a total intrinsic value of $40.2 million.
Performance Stock Unit Transactions	Performance stock unit transactions during the six month period ended July 31, 2021 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested units outstanding, January 30, 2021 148,668 $ 176.70 Units granted 50,044 324.28 Awards forfeited (16,011 ) 215.27 Non-vested units outstanding, July 31, 2021 182,701 213.74

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2021USD ($)Store$ / shares	Jan. 30, 2021USD ($)	Aug. 01, 2020USD ($)$ / shares	May 02, 2020USD ($)	Jul. 31, 2021USD ($)Store$ / shares	Aug. 01, 2020USD ($)$ / shares	Jun. 11, 2021USD ($)	Apr. 30, 2020USD ($)	Apr. 16, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 17, 2020USD ($)
Summary Of Significant Accounting Policies [Line Items]
Number of stores operated | Store	792				792
Medical benefit premiums paid during period furloughed	100.00%				100.00%
Decrease salary of executive leadership team					50.00%
Inventory markdown reserve				$ 271,900
Long term debt	$ 1,774,312	$ 1,927,770	$ 2,161,166		$ 1,774,312	$ 2,161,166
Accumulated earnings (deficit)	279,037	(11,702)	(175,712)		279,037	(175,712)
Deferred tax liabilities	$ 203,958	199,850	$ 217,387		$ 203,958	$ 217,387
Diluted net income per share | $ / shares	$ 1.50		$ (0.71)		$ 4.01	$ (5.79)
Accounting Standards Update (ASU) 2020-06 | Accounting Standards Update, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Additional paid-in capital	$ 176,000				$ 176,000
Long term debt	$ 153,000				$ 153,000
Diluted net income per share | $ / shares	$ 0.07				$ 0.12
Coronavirus Aid, Relief, and Economic Security Act | Prepaid and Other Current Assets
Summary Of Significant Accounting Policies [Line Items]
Tax refund from carryback of federal net operating loss		245,500
ABL senior secured revolving facility
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt			$ 250,000			$ 250,000				$ 400,000
Repayments of debt		250,000	150,000
Long-Term Debt, face amount	$ 600,000				$ 600,000					$ 600,000	$ 400,000
Convertible Senior Notes
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt	805,000	$ 648,311	633,076		805,000	633,076
Long-Term Debt, face amount	$ 805,000				$ 805,000			$ 805,000	$ 805,000
Debt Instrument, Interest Rate, Stated Percentage	2.25%				2.25%			2.25%	2.25%
Interest expense	$ 5,517		12,572		$ 11,028	14,902
Convertible Senior Notes | Accounting Standards Update (ASU) 2020-06 | Tax Effect, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Additional paid-in capital	44,100				44,100
Accumulated earnings (deficit)	5,900				5,900
Deferred tax liabilities	$ 38,300				$ 38,300
Convertible Senior Notes | Accounting Standards Update (ASU) 2020-06 | Accounting Standards Update, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	2.80%	8.20%			2.80%
Accumulated earnings (deficit)	$ 23,000				$ 23,000
Interest expense	7,700				15,300
Senior Secured Notes
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt		$ 300,000	$ 300,000			$ 300,000
Long-Term Debt, face amount	$ 300,000				$ 300,000		$ 300,000	$ 300,000	$ 300,000
Debt Instrument, Interest Rate, Stated Percentage	6.25%				6.25%			6.25%	6.25%

Company's Stockholders Equity (

Company's Stockholders Equity (Detail) - USD ($) $ in Thousands		3 Months Ended				6 Months Ended
		Jul. 31, 2021	May 01, 2021	Aug. 01, 2020	May 02, 2020	Jul. 31, 2021	Aug. 01, 2020
Balance at beginning of period		$ 539,892	$ 464,754	$ 279,101	$ 528,149	$ 464,754	$ 528,149
Net income (loss)		102,554	171,030	(46,781)	(333,728)	$ 273,584	(380,509)
Stock options exercised		12,811	16,089	19,530	1,454
Stock options exercised (in shares)	[1]					320,957
Shares used for tax withholding		$ (178)	(13,083)	(2,350)	(7,383)
Shares purchased as part of publicly announced programs					(50,158)
Vesting of restricted shares, net of forfeitures of restricted shares		660,000				711,000
Stock based compensation		$ 23,180	12,879	12,693	17,352
Equity component of convertible notes issuance, net of related taxes of $44.1 million					131,916
Unrealized losses on interest rate derivative contracts, net of related taxes benefit		(5,083)	825	(1,982)	(9,609)	$ (4,258)	(11,591)
Amount reclassified into earnings, net of related taxes		2,519	2,159	2,049	1,108	4,678	3,157
Balance at end of period		675,695	$ 539,892	262,260	279,101	675,695	262,260
Accounting Standards Update [Extensible List]			Accounting Standards Update (ASU) 2020-06
Cumulative-effect Adjustment
Balance at beginning of period		(114,761)
Balance at end of period			$ (114,761)
Common Stock
Balance at beginning of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at beginning of period (in shares)		80,897,050	80,661,453	80,084,171	79,882,506	80,661,453	79,882,506
Stock options exercised (in shares)		139,274	181,683	324,500	180,950
Vesting of restricted shares, net of forfeitures of restricted shares		5,645	53,914	5,480	20,715
Balance at end of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at end of period (in shares)		81,041,969	80,897,050	80,414,151	80,084,171	81,041,969	80,414,151
Additional Paid-in Capital
Balance at beginning of period		$ 1,706,883	$ 1,809,831	$ 1,737,868	$ 1,587,146	$ 1,809,831	$ 1,587,146
Stock options exercised		12,811	16,089	19,530	1,454
Stock based compensation		23,180	12,879	12,693	17,352
Equity component of convertible notes issuance, net of related taxes of $44.1 million					131,916
Balance at end of period		1,742,874	1,706,883	1,770,091	1,737,868	1,742,874	1,770,091
Additional Paid-in Capital | Cumulative-effect Adjustment
Balance at beginning of period		(131,916)
Balance at end of period			(131,916)
Accumulated Earnings (Deficit)
Balance at beginning of period		176,483	(11,702)	(128,931)	204,797	(11,702)	204,797
Net income (loss)		102,554	171,030	(46,781)	(333,728)
Balance at end of period		279,037	176,483	(175,712)	(128,931)	279,037	(175,712)
Accumulated Earnings (Deficit) | Cumulative-effect Adjustment
Balance at beginning of period		17,155
Balance at end of period			17,155
Accumulated Other Comprehensive Loss
Balance at beginning of period		(20,031)	(23,015)	(27,461)	(18,960)	(23,015)	(18,960)
Unrealized losses on interest rate derivative contracts, net of related taxes benefit		(5,083)	825	(1,982)	(9,609)
Amount reclassified into earnings, net of related taxes		2,519	2,159	2,049	1,108
Balance at end of period		(22,595)	(20,031)	(27,394)	(27,461)	(22,595)	(27,394)
Treasury Stock
Balance at beginning of period		$ (1,323,450)	$ (1,310,367)	$ (1,302,382)	$ (1,244,841)	$ (1,310,367)	$ (1,244,841)
Balance at beginning of period (in shares)		(14,316,890)	(14,275,122)	(14,237,470)	(13,952,534)	(14,275,122)	(13,952,534)
Shares used for tax withholding		$ (178)	$ (13,083)	$ (2,350)	$ (7,383)
Shares used for tax withholding (in shares)		(603)	(41,768)	(13,108)	(41,363)
Shares purchased as part of publicly announced programs					$ (50,158)
Shares purchased as part of publicly announced programs, (in shares)					(243,573)
Balance at end of period		$ (1,323,628)	$ (1,323,450)	$ (1,304,732)	$ (1,302,382)	$ (1,323,628)	$ (1,304,732)
Balance at end of period (in shares)		(14,317,493)	(14,316,890)	(14,250,578)	(14,237,470)	(14,317,493)	(14,250,578)
[1]	Options exercised during the six month period ended July 31, 2021 had a total intrinsic value of $ 70.1

Company's Stockholders Equity_2

Company's Stockholders Equity (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Jul. 31, 2021	May 01, 2021	Aug. 01, 2020	May 02, 2020
Statement Of Stockholders Equity [Abstract]
Forfeited restricted shares	1,101	883	2,499	4,166
Unrealized losses on interest rate derivative contracts, Tax	$ 1.9	$ 0.3	$ 0.7	$ 3.6
Amount reclassified into earnings on Interest Rate Cap Contracts, Tax	$ 0.9	$ 0.8	$ 0.8	0.4
Equity component of convertible notes issuance, related taxes				$ 44.1

Lease Commitments - Additional

Lease Commitments - Additional Information (Detail) $ in Millions	6 Months Ended
	Jul. 31, 2021USD ($)Store
Future Minimum Payments Receivable [Line Items]
Operating and finance leases, expiration period	30 years
Leases renewal option	5 years
Accrued lease liability	$ 494
Number of store committed to open or relocate but has not yet taken possession | Store	96
Other Current Liabilities | Coronavirus Aid, Relief, and Economic Security Act
Future Minimum Payments Receivable [Line Items]
Deferred lease payments	$ 11.6

Future Lease Payments (Detail)

Future Lease Payments (Detail) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Operating Leases
2021 (remainder)	$ 226,021
2022	472,683
2023	449,112
2024	414,152
2025	380,927
2026	342,129
Thereafter	1,121,958
Total future minimum lease payments	3,406,982
Amount representing interest	(651,385)
Total lease liabilities	2,755,597
Less: current portion of lease liabilities	(326,282)	$ (304,629)	$ (277,211)
Total long term lease liabilities	$ 2,429,315	$ 2,400,782	$ 2,390,344
Weighted average discount rate	5.20%
Weighted average remaining lease term (years)	8 years 2 months 12 days
Finance Leases
2021 (remainder)	$ 3,693
2022	7,513
2023	7,589
2024	7,417
2025	5,287
2026	5,324
Thereafter	28,014
Total future minimum lease payments	64,837
Amount representing interest	(18,727)
Total lease liabilities	46,110
Less: current portion of lease liabilities	(4,481)
Total long term lease liabilities	$ 41,629
Weighted average discount rate	6.80%
Weighted average remaining lease term (years)	11 years 4 months 24 days

Schedule of Net Lease Costs (De

Schedule of Net Lease Costs (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Finance lease cost:
Amortization of finance lease asset	[1]	$ 1,132	$ 1,211	$ 2,274	$ 2,422
Interest on lease liabilities	[2]	790	857	1,598	1,729
Operating lease cost	[3]	115,771	109,592	226,930	218,565
Variable lease cost	[3]	46,165	45,643	92,912	86,861
Total lease cost		163,858	157,303	323,714	309,577
Less all rental income	[4]	(1,354)	(1,265)	(2,629)	(2,513)
Total net rent expense	[5]	$ 162,504	$ 156,038	$ 321,085	$ 307,064
[1]	Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss).
[2]	Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss).
[3]	Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).
[4]	Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss).
[5]	Excludes an immaterial amount of short-term lease cost.

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Disclosures Related to Leases (Details) - USD ($) $ in Thousands		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Cash payments arising from operating lease liabilities	[1]	$ 242,905	$ 169,391
Cash payments for the principal portion of finance lease liabilities	[2]	1,908	1,743
Cash payments for the interest portion of finance lease liabilities	[1]	1,598	1,729
Operating lease liabilities arising from obtaining right-of-use assets		$ 203,396	$ 228,344
[1]	Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows.
[2]	Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020	Apr. 16, 2020	Mar. 31, 2020
Debt Instrument [Line Items]
Finance lease obligations	$ 46,110	$ 47,664	$ 48,848
Unamortized deferred financing costs	(17,708)	(22,724)	(25,023)
Total debt	1,788,407	1,931,669	2,164,926
Less: current maturities	(14,095)	(3,899)	(3,760)
Long term debt, net of current maturities	1,774,312	1,927,770	2,161,166
Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long Term Debt	955,005
Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long Term Debt		958,418	958,025
Convertible Senior Notes
Debt Instrument [Line Items]
Long Term Debt	$ 805,000	648,311	633,076
Unamortized deferred financing costs				$ (21,000)
Senior Secured Notes
Debt Instrument [Line Items]
Long Term Debt		$ 300,000	300,000
Unamortized deferred financing costs				$ (7,900)
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long Term Debt			$ 250,000		$ 400,000

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Apr. 16, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021	Jun. 11, 2021	Apr. 30, 2020	Mar. 31, 2020	Mar. 17, 2020
Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Jun. 24, 2028	Jun. 24, 2028	Jun. 24, 2028
Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, redemption date		Jun. 24, 2021	Jun. 24, 2021	Jun. 24, 2021
Convertible Senior Notes
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Apr. 15, 2025	Apr. 15, 2025
Long-Term Debt, face amount	$ 805,000	$ 805,000				$ 805,000
Long-Term Debt, interest rate	2.25%	2.25%				2.25%
Senior Secured Notes
Debt Instrument [Line Items]
Long-Term Debt, redemption date		Jun. 11, 2021
Long-Term Debt, face amount	$ 300,000	$ 300,000			$ 300,000	$ 300,000
Long-Term Debt, interest rate	6.25%	6.25%				6.25%
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Jun. 29, 2023
Long-Term Debt, face amount		$ 600,000					$ 600,000	$ 400,000
London Interbank Offered Rate Floor | Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0.00%	0.00%	0.00%
London Interbank Offered Rate Floor | Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0.00%	0.00%	0.00%
London Interbank Offered Rate (LIBOR) | Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		2.00%	2.00%	2.00%
London Interbank Offered Rate (LIBOR) | Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		1.75%	1.75%	1.75%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)	Jun. 24, 2021USD ($)	Jun. 23, 2021	Jun. 11, 2021USD ($)	Apr. 16, 2020USD ($)shares$ / shares	Feb. 26, 2020USD ($)	Feb. 25, 2020	Jul. 31, 2021USD ($)	Jan. 30, 2021USD ($)	Aug. 01, 2020USD ($)	Jul. 31, 2021USD ($)	Aug. 01, 2020USD ($)	Apr. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 17, 2020USD ($)
Debt Instrument [Line Items]
Costs related to debt issuances and amendments							$ 3,331,000			$ 3,331,000	$ 4,352,000
Loss on extinguishment of debt							(31,395,000)			(31,395,000)	(202,000)
Deferred financing costs							$ 17,708,000	$ 22,724,000	$ 25,023,000	$ 17,708,000	$ 25,023,000
Term Loan Facility
Debt Instrument [Line Items]
Borrowing, interest rate							2.10%		1.90%	2.10%	1.90%
Convertible Senior Notes
Debt Instrument [Line Items]
Debt instrument maturity date				Apr. 15, 2025						Apr. 15, 2025
Borrowing, interest rate				8.20%
Long-Term Debt, face amount				$ 805,000,000			$ 805,000,000			$ 805,000,000		$ 805,000,000
Long-Term Debt, conversion of convertible notes | shares				3,656,149
Long-Term Debt, conversion of convertible notes subject to adjustments | shares				4,844,410
Long-Term Debt, interest rate				2.25%			2.25%			2.25%		2.25%
Debt instrument frequency of periodic payments				semi-annually
Debt instrument, date of first required payment				Oct. 15, 2020
Debt instrument, conversion ratio				4.5418
Debt instrument, principal amount for conversion				$ 1,000
Debt instrument, conversion price | $ / shares				$ 220.18
Debt instrument, conversion premium				32.50%
Share price | $ / shares				$ 166.17
Debt instrument, convertible, stock price trigger				130.00%
Debt instrument, redemption price, percentage				100.00%
Debt instrument repurchase percentage on conditional basis				100.00%
Deferred financing costs				$ 21,000,000
Convertible Senior Notes | Accounting Standards Update (ASU) 2020-06
Debt Instrument [Line Items]
Borrowing, interest rate				2.80%
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Deferred financing costs				$ 16,400,000			$ 15,846,000	14,191,000	$ 15,571,000	$ 15,846,000	$ 15,571,000
Convertible Senior Notes | Equity Component
Debt Instrument [Line Items]
Deferred financing costs				4,600,000
Senior Secured Notes
Debt Instrument [Line Items]
Loss on extinguishment of debt							30,200,000
Long-Term Debt, face amount			$ 300,000,000	$ 300,000,000			$ 300,000,000			$ 300,000,000		$ 300,000,000
Long-Term Debt, interest rate				6.25%			6.25%			6.25%		6.25%
Debt instrument frequency of periodic payments				semiannually
Debt instrument, date of first required payment				Oct. 15, 2020
Deferred financing costs				$ 7,900,000
Debt instrument legal fees				$ 2,500,000
Debt instrument, redemption price			$ 323,700,000
ABL senior secured revolving facility
Debt Instrument [Line Items]
Debt instrument maturity date										Jun. 29, 2023
Long-Term Debt, face amount							$ 600,000,000			$ 600,000,000			$ 600,000,000	$ 400,000,000
Repayments of debt								$ 250,000,000	150,000,000
Line of Credit Facility, amount available							533,600,000		120,400,000	533,600,000	120,400,000
Line of Credit Facility, amount outstanding during period							$ 0			$ 0
Line of Credit Facility, maximum amount outstanding during period									400,000,000		400,000,000
Line of Credit Facility, Average borrowings									$ 372,000,000		$ 289,300,000
Line of Credit Facility, Average interest rate									2.10%		2.10%
Term Loan Facility
Debt Instrument [Line Items]
Costs related to debt issuances and amendments	$ 3,300,000				$ 1,100,000
Debt instrument maturity date	Jun. 24, 2028	Nov. 17, 2024
Quarterly principal payments	$ 2,400,000
Term Loan Facility | Write Off Deferred Financing Costs
Debt Instrument [Line Items]
Loss on extinguishment of debt	$ (1,200,000)				$ (200,000)
Term Loan Facility | Prime Rate
Debt Instrument [Line Items]
Line of Credit Facility, interest rate	1.00%	0.75%			0.75%	1.00%
Term Loan Facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Line of Credit Facility, interest rate	2.00%	1.75%			1.75%	2.00%
Term Loan Facility | London Interbank Offered Rate Floor
Debt Instrument [Line Items]
Line of Credit Facility, interest rate	0.00%				0.00%

Long-Term Debt - Schedule of Co

Long-Term Debt - Schedule of Components of Convertible Notes (Detail) - USD ($) $ in Thousands		Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020	Apr. 16, 2020
Debt Instrument [Line Items]
Principal	[1]	$ 1,766,415	$ 2,066,415	$ 2,316,415
Unamortized deferred financing costs		(17,708)	(22,724)	(25,023)
Convertible Senior Notes
Debt Instrument [Line Items]
Unamortized deferred financing costs					$ (21,000)
Net carrying amount		805,000	648,311	633,076
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Principal		805,000	805,000	805,000
Unamortized debt discount			(156,689)	(171,924)
Unamortized deferred financing costs		(15,846)	(14,191)	(15,571)	(16,400)
Net carrying amount		$ 789,154	634,120	617,505
Convertible Senior Notes | Equity Component
Debt Instrument [Line Items]
Unamortized deferred financing costs					$ (4,600)
Net carrying amount			$ 131,916	$ 131,916
[1]	The table above excludes finance lease obligations, debt discount and deferred debt costs.

Long-Term Debt - Schedule of In

Long-Term Debt - Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Debt Instrument [Line Items]
Amortization of deferred financing costs			$ 3,100	$ 1,786
Convertible Senior Notes
Debt Instrument [Line Items]
Coupon interest	$ 4,510	$ 4,513	9,021	5,356
Amortization of debt discount		7,387		8,753
Amortization of deferred financing costs	1,007	672	2,007	793
Convertible Notes interest expense	$ 5,517	$ 12,572	$ 11,028	$ 14,902

Derivative Instruments And He_3

Derivative Instruments And Hedging Activities - Additional Information (Detail)	Jun. 24, 2021USD ($)	Dec. 17, 2018USD ($)	Jul. 31, 2021USD ($)Derivative
Interest Rate Cap Contracts
Derivative [Line Items]
Number of credit risk derivatives held | Derivative			1
Amounts reported in Accumulated Other Comprehensive Loss to be reclassified to interest expense, during the next twelve months			$ 6,700,000
Interest Rate Swap Contract | Cash Flow Hedging | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Notional aggregate principal amount	$ 450,000,000	$ 450,000,000	$ 450,000,000
Interest swap rate	2.19%	2.72%	2.19%
Amount of loss deferred for previous interest rate swap		$ 26,900,000
Interest rate swap liability fair value	$ 26,900,000
Maturity date	Jun. 24, 2028	Dec. 29, 2023	Jun. 24, 2028

Outstanding Interest Rate Deriv

Outstanding Interest Rate Derivative in Qualifying Hedging Relationships (Detail) - Cash Flow Hedging - Derivatives Designated as Hedging Instruments - Interest Rate Swap Contract	Jun. 24, 2021USD ($)	Dec. 17, 2018USD ($)	Jul. 31, 2021USD ($)Derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments | Derivative			1
Notional aggregate principal amount | $	$ 450,000,000	$ 450,000,000	$ 450,000,000
Interest Swap Rate	2.19%	2.72%	2.19%
Maturity Date	Jun. 24, 2028	Dec. 29, 2023	Jun. 24, 2028

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Detail) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Interest Rate Swap Contract | Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value	$ 31,764	$ 31,665	$ 37,798

Summary of Unrealized Gains and

Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2021	May 01, 2021	Aug. 01, 2020	May 02, 2020	Jul. 31, 2021	Aug. 01, 2020
Derivative Instruments Gain Loss [Line Items]
Income tax benefit	$ 1,900	$ 300	$ 700	$ 3,600
Unrealized losses, net of taxes	(5,083)	$ 825	(1,982)	$ (9,609)	$ (4,258)	$ (11,591)
Derivatives Designated as Hedging Instruments | Interest Rate Derivatives
Derivative Instruments Gain Loss [Line Items]
Unrealized losses, before taxes	(6,972)		(2,730)		(5,840)	(15,894)
Income tax benefit	1,889		748		1,582	4,303
Unrealized losses, net of taxes	$ (5,083)		$ (1,982)		$ (4,258)	$ (11,591)

Reclassification of Gains and L

Reclassification of Gains and Losses from Accumulated Other Comprehensive Loss into Earnings (Detail) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2021	May 01, 2021	Aug. 01, 2020	May 02, 2020	Jul. 31, 2021	Aug. 01, 2020
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	$ 17,502		$ 28,359		$ 37,101	$ 43,052
Income tax benefit	21,210		(63,055)		61,847	(268,415)
Net reclassification into earnings	(2,519)	$ (2,159)	(2,049)	$ (1,108)	(4,678)	(3,157)
Reclassification out of accumulated other comprehensive income | Derivatives Designated as Hedging Instruments | Accumulated net gain (loss) from cash flow hedges including portion attributable to noncontrolling interest | Interest Rate Cap Contracts
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	3,459		2,820		6,423	4,352
Income tax benefit	(940)		(771)		(1,745)	(1,195)
Net reclassification into earnings	$ 2,519		$ 2,049		$ 4,678	$ 3,157

Fair Values of Financial Assets

Fair Values of Financial Assets and Hierarchy of Level of Inputs (Detail) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents (including restricted cash)	$ 701,577	$ 1,001,475	$ 1,001,253

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021USD ($)	Aug. 01, 2020USD ($)	Jul. 31, 2021USD ($)Store	Aug. 01, 2020USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment charges - long-lived assets | $	$ 970	$ 1,077	$ 1,747	$ 3,001
Fair Value, Inputs, Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset associated with sale remaining fair value | $	$ 2,500		$ 2,500
Assets Impairments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Number of stores expected to sale | Store			1
Impairment of store level assets, number of stores | Store			1

Fair Values of Financial Liabil

Fair Values of Financial Liabilities (Detail) - USD ($) $ in Thousands		Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[1]	$ 1,766,415	$ 2,066,415	$ 2,316,415
Long-Term Debt, Fair Value	[1]	2,273,937	2,356,744	2,380,491
Term B-6 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		961,415
Long-Term Debt, Fair Value		954,204
Term B-5 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount			961,415	961,415
Long-Term Debt, Fair Value			955,406	914,546
Convertible Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		805,000	805,000	805,000
Long-Term Debt, Fair Value		$ 1,319,733	1,080,713	896,070
Secured Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount			300,000	300,000
Long-Term Debt, Fair Value			$ 320,625	319,875
ABL Line of Credit
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[2]			250,000
Long-Term Debt, Fair Value	[2]			$ 250,000
[1]	The table above excludes finance lease obligations, debt discount and deferred debt costs.
[2]	To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to short term nature.

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Jan. 30, 2021
Income Tax Disclosure [Line Items]
Income tax expense (benefit)	$ 21,210	$ (63,055)	$ 61,847	$ (268,415)
Effective tax rate	17.10%	57.40%	18.40%	41.40%
Deferred tax asset for net operating loss	$ 31,300		$ 31,300
Valuation allowances	11,300	$ 11,500	11,300	$ 11,500	$ 13,000
Puerto Rico
Income Tax Disclosure [Line Items]
Tax credit carryforwards	6,900		6,900
Amount of alternative minimum tax credits	1,000		$ 1,000
Alternative minimum tax credits, expiration life			indefinite life
State and local jurisdiction
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	31,000		$ 31,000
Tax credit carryforwards	5,900		$ 5,900
Tax credit expiration period			2023
State and local jurisdiction | Minimum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2022
State and local jurisdiction | Maximum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2040
Puerto Rico
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	$ 300		$ 300
Net operating losses subject to expiration year			2025

Net Deferred Taxes (Detail)

Net Deferred Taxes (Detail) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 4,197	$ 4,422	$ 4,678
Deferred tax liability	203,958	199,850	217,387
Net deferred tax liability	$ 199,761	$ 195,428	$ 212,709

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)	Aug. 18, 2021	Aug. 14, 2019	Jul. 31, 2021	May 01, 2021	Aug. 01, 2020	May 02, 2020	Jul. 31, 2021
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings			$ 178,000	$ 13,083,000	$ 2,350,000	$ 7,383,000
2019 Stock Repurchase Programs
Statement Equity Components [Line Items]
Stock repurchase programs, authorized amount		$ 400,000,000
Stock repurchase programs, authorized execution month and year		2021-08
2020 Stock Repurchase Programs
Statement Equity Components [Line Items]
Remaining authorized repurchase amount			$ 348,400,000				$ 348,400,000
Share repurchase program expiration date							Aug. 31, 2021
2021 Stock Repurchase Programs | Subsequent Event
Statement Equity Components [Line Items]
Stock repurchase programs, authorized amount	$ 400,000,000
Stock repurchase programs, authorized execution month and year	2023-08
Treasury Stock
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings (in shares)							42,371
Shares Used for Tax Withholdings							$ 13,300,000

Computation of Basic and Dilute

Computation of Basic and Diluted Net Income (Loss) per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Basic net income (loss) per share
Net income (loss)	$ 102,554	$ (46,781)	$ 273,584	$ (380,509)
Weighted average number of common shares – basic	66,636	65,947	66,516	65,760
Net income (loss) per common share – basic	$ 1.54	$ (0.71)	$ 4.11	$ (5.79)
Diluted net income (loss) per share
Net income (loss)	$ 102,554	$ (46,781)	$ 273,584	$ (380,509)
Weighted average number of common shares – basic	66,636	65,947	66,516	65,760
Assumed exercise of stock options and vesting of restricted stock	660		711
Assumed conversion of convertible debt	1,152		1,013
Weighted average number of common shares – diluted	68,448	65,947	68,240	65,760
Net income (loss) per common stock - diluted	$ 1.50	$ (0.71)	$ 4.01	$ (5.79)

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Additional Information (Detail) - shares	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net (loss) income per share	185,000		95,000
Stock Option, Restricted Stock and Restricted Stock Unit Awards
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net (loss) income per share		2,005,000		2,015,000

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail)	6 Months Ended
	Jul. 31, 2021shares
Performance Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, vesting period	3 years
Performance Stock Units | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	50.00%
Performance Stock Units | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	200.00%
2013 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant equity awards	1,994,299

Non-Cash Stock Compensation Exp

Non-Cash Stock Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[1]	$ 23,180	$ 12,693	$ 36,059	$ 30,045
Restricted Stock and Restricted Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	7,684	5,739	13,940	12,638
Stock Option Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	4,682	4,696	9,076	11,028
Performance Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	$ 10,814	$ 2,258	$ 13,043	$ 6,379
[1]	The amounts presented in the table above exclude taxes. For the three and six month periods ended July 31, 2021, the tax benefit related to the Company’s non-cash stock compensation was approximately $3.7 million and $6.1 million, respectively. For the three and six month periods ended August 1, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.2 million and $6.0 million, respectively.
[2]	Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).

Non-Cash Stock Compensation E_2

Non-Cash Stock Compensation Expense (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation tax benefit	$ 3.7	$ 2.2	$ 6.1	$ 6

Stock Option Transactions (Deta

Stock Option Transactions (Detail)	6 Months Ended
	Jul. 31, 2021$ / sharesshares
Number of Shares
Options Outstanding at Beginning of Period | shares	1,346,775
Options Granted | shares	165,775
Options Exercised | shares	(320,957)	[1]
Options Forfeited | shares	(32,324)
Options Outstanding at End of Period | shares	1,159,269
Weighted Average Exercise Price Per Share
Options Outstanding at Beginning of Period | $ / shares	$ 133.86
Options Granted | $ / shares	324.91
Options Exercised | $ / shares	90.05	[1]
Options Forfeited | $ / shares	190.33
Options Outstanding at End of Period | $ / shares	$ 171.73
[1]	Options exercised during the six month period ended July 31, 2021 had a total intrinsic value of $ 70.1

Stock Option Transactions (Pare

Stock Option Transactions (Parenthetical) (Detail) $ in Millions	6 Months Ended
	Jul. 31, 2021USD ($)
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share based compensation option exercised total intrinsic value	$ 70.1

Stock Options Vested and Expect

Stock Options Vested and Expected to Vest (Detail) $ / shares in Units, $ in Millions	6 Months Ended
	Jul. 31, 2021USD ($)$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Vested and expected to vest, Options | shares	1,159,269
Vested and expected to vest, Weighted Average Remaining Contractual Life (Years)	6 years 8 months 12 days
Vested and expected to vest, Weighted Average Exercise Price | $ / shares	$ 171.73
Vested and expected to vest, Aggregate Intrinsic Value | $	$ 189
Options exercisable, Options | shares	529,381
Options exercisable, Weighted Average Remaining Contractual Life (Years)	4 years 10 months 24 days
Options exercisable, Weighted Average Exercise Price | $ / shares	$ 128.54
Options exercisable, Aggregate Intrinsic Value | $	$ 109.2

Weighted Average Assumptions Us

Weighted Average Assumptions Used to Estimate Fair Value of Stock Option (Detail)	6 Months Ended
	Jul. 31, 2021$ / shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Risk-free interest rate, minimum	0.45%
Risk-free interest rate, maximum	1.13%
Expected volatility, minimum	34.00%
Expected volatility, maximum	35.00%
Expected life (years)	6 years 3 months
Contractual life (years)	10 years
Expected dividend yield	0.00%
Weighted average grant date fair value of options issued	$ 113.59

Award Grant, Vested and Forfeit

Award Grant, Vested and Forfeiture Transactions (Detail) - Non Vested Restricted Stock	6 Months Ended
	Jul. 31, 2021$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	396,555
Awards Granted | shares	120,945
Awards Vested | shares	(127,445)	[1]
Awards Forfeited | shares	(14,442)
Non-Vested Awards Outstanding at End of Period | shares	375,613
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 168.87
Awards Granted | $ / shares	324.83
Awards Vested | $ / shares	145.26	[1]
Awards Forfeited | $ / shares	199.55
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 225.92
[1]	Restricted stock awards vested during the six month period ended July 31, 2021 had a total intrinsic value of $40.2 million.

Award Grant, Vested and Forfe_2

Award Grant, Vested and Forfeiture Transactions (Parenthetical) (Detail) $ in Millions	6 Months Ended
	Jul. 31, 2021USD ($)
Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 40.2

Performance Stock Units Transac

Performance Stock Units Transactions (Detail) - Performance Stock Units	6 Months Ended
	Jul. 31, 2021$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	148,668
Awards Granted | shares	50,044
Awards Forfeited | shares	(16,011)
Non-Vested Awards Outstanding at End of Period | shares	182,701
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 176.70
Awards Granted | $ / shares	324.28
Awards Forfeited | $ / shares	215.27
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 213.74

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Jul. 31, 2021	Jan. 30, 2021	Aug. 01, 2020	Nov. 30, 2005
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	$ 65,300,000	$ 54,900,000	$ 53,900,000
Purchase commitments related to goods or services	1,959,700,000
Death benefits				$ 1,000,000
Guarantee Performance Under Insurance And Utility Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	46,700,000	46,800,000	47,200,000
Merchandising Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	18,600,000	8,200,000	6,700,000
Letters of Credit | ABL senior secured revolving facility
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, maximum borrowing capacity	$ 533,600,000	$ 476,800,000	$ 120,400,000